Literature DB >> 13826057

Urea as an osmotic ocular hypotensive agent in glaucoma.

M A GALIN, F AIZAWA, J M McLEAN.   

Abstract

Entities:  

Keywords:  GLAUCOMA/therapy; UREA/therapy

Mesh:

Substances:

Year:  1959        PMID: 13826057     DOI: 10.1001/archopht.1959.04220030003001

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  13 in total

1.  GLAUCOMA DUE TO HYPERMATURE CATARACT: THE USE OF UREA IN DIAGNOSIS.

Authors:  M L KWITKO
Journal:  Can Med Assoc J       Date:  1963-09-14       Impact factor: 8.262

2.  Evaluation of the influence of T.H.A.M. on intraocular pressure.

Authors:  I H LEOPOLD; R J KIRSCHNER; D PRAEGER
Journal:  Trans Am Ophthalmol Soc       Date:  1962

3.  Diuretics and the eye.

Authors:  D A CAMPBELL
Journal:  Br Med J       Date:  1961-08-19

4.  The effect of reduced blood osmolality on intraocular pressure.

Authors:  J M MCLEAN; M A GALIN
Journal:  Trans Am Ophthalmol Soc       Date:  1960

5.  Total Hyphema with Special Reference to Treatment of the Experimental Lesion.

Authors:  S D Liebman
Journal:  Trans Am Ophthalmol Soc       Date:  1963

6.  INTRAVENOUS UREA THERAPY IN GLAUCOMA.

Authors:  S J Crews; S I Davidson
Journal:  Br J Ophthalmol       Date:  1961-12       Impact factor: 4.638

7.  INTRAVENOUS UREA IN GLAUCOMA.

Authors:  C G Keith
Journal:  Br J Ophthalmol       Date:  1961-04       Impact factor: 4.638

8.  Urea therapy in glaucoma due to secondary hyphema.

Authors:  M L KWITKO; F D COSTENBADER
Journal:  Can Med Assoc J       Date:  1962-03-10       Impact factor: 8.262

9.  Increased aqueous flare as a result of a therapeutic dose of mannitol in humans.

Authors:  K Miyake; Y Miyake; K Maekubo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  Ciruclation in the head and intra-ocular pressure. An analysis of the correlation and interactions between blood pressure, blood flow, osmotic pressure, hematocrit and intra-ocular pressure.

Authors:  D Kaskel; H Fink
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.